To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
Ovarian Cancer Education Ira Winer, M.D., Ph.D., FACOG , gynecologic oncologist and member of the Gynecologic Oncology and Phase I Clinical-Pharmacology Multidisciplinary Teams at Karmanos Cancer Institute, along with Jennifer Land, RN, a clinical trials nurse at Karmanos are featured on an episode of the Ovarian Cancer Education Podcast to discuss clinical trials. Listen to the podcast episode here. Click here to learn more about clinical trials at Barbara Ann Karmanos Cancer Institute.
CancerNetwork Ira Winer, M.D., Ph.D., FACOG , member of the Gynecologic Oncology and Phase I Clinical-Pharmacology Multidisciplinary Teams at Karmanos, spoke about the future directions of nemvaleukin alfa plus pembrolizumab for patients with pretreated resistant ovarian cancer. Listen to his interview with CancerNetwork here .
CancerNetwork Ira Winer, M.D., Ph.D., FACOG , member of the Gynecologic Oncology Multidisciplinary Team at Karmanos, recently presented Clinical Outcomes of Ovarian Cancer Patients Treated with the Novel Engineered Cytokine Nemvaleukin Alfa in Combination with the PD-1 Inhibitor Pembrolizumab: Recent Data from ARTISTRY-1 at The Society of Gynecologic Oncology (SGO) 2022 Annual Meeting on Women’s Cancer. Following the conference, Dr. Winer speaks to the CancerNetwork about the presentations he found most...